 | Outlook Therapeutics, Inc. | |||
| NCM : OTLK || Location: United States | ||||
$8.43+0.24 (+2.93%) |
0.12 M | 8.14 - 8.5 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 1.130 M |
| March 28, 2024 | 1.326 M |
| March 15, 2024 | 0.785 M |
| Feb. 29, 2024 | 11.643 M |
| Feb. 15, 2024 | 13.198 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -1.02 | -0.80 | 21.57% |
| 09/30/2023 | -0.06 | -0.05 | 16.53% |
| 06/30/2023 | -1.05 | -1.60 | -52.50% |
| 03/31/2023 | -0.07 | -0.03 | 54.75% |
| 12/31/2022 | -0.05 | -0.08 | -49.25% |
OTLK Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 23.299M | Shares Float | 5.875M |
| Short Float | 1.130M | Market Cap | 190.82M |
| Institution ownership | 22.74% | Insider ownership | 38.847% |
| Earnings Date | 05/13/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -4.00 | Forward EPS | -2.02 |